Fighting COVID-19 at the FDA
FDA Commissioner Dr. Stephen Hahn, and FDA Deputy Commissioner for Medical and Scientific Affairs Dr. Anand Shah discuss FDA's COVID-19 efforts, including the drug development process for a COVID-19...
View ArticleAll About COVID-19 Testing
Dr. Anand Shah, FDA's Deputy Commissioner for Medical and Scientific Affairs, welcomes Toby Lowe, the Associate Director of the Office of In Vitro Diagnostics and Radiological Health, to discuss the...
View ArticleFood Safety and COVID-19
FDA Commissioner Stephen M. Hahn, M.D., returns to FDA Insight to discuss food safety issues during the COVID-19 pandemic.
View ArticleClinical Trials and Treatments for COVID-19
Dr. Patrizia Cavazzoni, the acting director of FDA’s Center for Drug Evaluation and Research, joins Dr. Shah for an in-depth discussion on clinical trials and treatments for COVID-19. A list of...
View ArticleVaccines for COVID-19, Part 1
In Part 1 of FDA Insight’s vaccine series, Dr. Shah welcomes Dr. Peter Marks, director of FDA’s Center for Biologics Evaluation and Research, to discuss the basics of COVID-19 vaccine development.
View ArticleVaccines for COVID-19, Part 2
Dr. Peter Marks returns for a more comprehensive discussion on vaccines as they relate to COVID-19. Find out more about “herd immunity,” Operation Warp Speed, and vaccine distribution in this episode.
View ArticleA “Topical” Discussion on Sunscreen
During the summer, fun in the sun is a high priority for many families, but what do you really know about that sunscreen protecting you? Dr. Terri Michele, the Director of the Office of...
View ArticleYour Digital Health
Dr. Shah welcomes Bakul Patel, the director of Digital Health at FDA’s Center for Devices and Radiological Health, to discuss telemedicine, digital health tools, and FDA’s new Digital Health Center of...
View ArticleHealth Fraud and COVID-19
Dr. Judy McMeekin, the Associate Commissioner for Regulatory Affairs, joins Dr. Shah on the show to discuss FDA's fight against health fraud during the COVID-19 pandemic.
View ArticleDrug Shortages and COVID-19
Valerie Jensen, the Associate Director of the Drug Shortages staff in FDA's Center for Drug Evaluation and Research, joins Dr. Shah for a discussion on drug shortages and how the COVID-19 pandemic can...
View ArticleThe Opioid Epidemic and COVID-19 Pandemic
Dr. Shah welcomes Megan Moncur, FDA’s Associate Director of Opioid Policy, to the show to discuss the opioid epidemic and how it’s been impacted by the COVID-19 pandemic.
View ArticleE-Cigarettes and the National Youth Tobacco Survey
Mitch Zeller, Director of FDA's Center for Tobacco Products, joins Dr. Shah in a discussion on e-cigarettes (or vapes) and the 2020 National Youth Tobacco Survey results. For more on how you can stop...
View ArticleA Closer Look at Nutrition
Dr. Shah welcomes Dr. Susan Mayne, Director of FDA's Center for Food Safety and Applied Nutrition, to discuss nutrition and chronic disease prevention, including health disparities.
View ArticleAnti-Microbial Resistance
Dr. Shah welcomes Dr. Steve Solomon, Director of FDA's Center for Veterinary Medicine, to discuss the work CVM is doing in combating antimicrobial resistance.
View ArticleAn Insight into Women’s Health
Dr. Kaveeta Vasisht, FDA's Associate Commissioner for Women's Health, joins FDA Insight to discuss the Office of Women's Health's work to advance the health of women through scientific programs, policy...
View ArticleAdvisory Committee on COVID-19 Vaccines
Dr. Peter Marks, FDA's Director of the Center for Biologics Evaluation and Research, returns for his third episode to provide an update on COVID-19 vaccines and to discuss the upcoming Vaccines and...
View ArticleGet Your Flu Vaccine
On this week's episode, Dr. Shah brings Dr. Peter Marks back to the show to discuss the importance of getting the flu vaccine. For more information about the flu vaccine, visit: https://www.fda.gov/flu
View ArticleHand Hygiene During COVID-19
Dr. Shah welcomes Elizabeth Jungman, director of CDER’s Office of Regulatory Policy, to talk about hand sanitizers and the COVID-19 pandemic.
View ArticlePersonal Protective Equipment and COVID-19
Dr. Shah welcomes Dr. Suzanne Schwartz, director of FDA’s Office of Strategic Partnerships and Technology Innovation at the Center for Devices and Radiological Health, for a discussion on personal...
View ArticleRare Diseases and Orphan Products
Dr. Shah welcomes Dr. Janet Maynard, director of FDA’s Office of Orphan Products Development, for a discussion on the agency’s work advancing evaluation and development of products that demonstrate...
View Article